 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| Exciting Update for CIIX : Overall Revenues Increased 175% |
|
 Hot Stock to Watch |
Company: Chineseinvestors.com, Inc. (OTCQB: CIIX)
|
Last:
Price: 0.18
Change (%): - 0.01 (5.26)
Volume: 15,000 |
 |
ChineseInvestors.com, Inc.'s Shareholder Update
SAN GABRIEL, Calif., Nov. 11, 2019 /PRNewswire/ - ChineseInvestors.com, Inc. (OTCQB:CIIX) (“CIIX” or “the Company”), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today provides a second quarter update for FY 2020 from its Executive Team.
Two decades ago, we started down a path to build our financial news and education business from the ground up, and over the years, we believe the Chinese-speaking community has come to rely on ChineseInvestors.com, Inc.to deliver this information through new and innovative products and offerings. This is evidenced by our shareholder loyalty and support over the years.
Typical of many developing companies, revenue comes at the expense of profitability. Overall revenues increased 175% to $6,476,442 for the year ended May 31, 2019 from $2,353,331 in the year ended May 31, 2018. This was largely attributed to the Company’s subsidiary in China, CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands (“CBD Biotech). In addition, our core business of financial news/education and investor relations, which targets the Chinese-speaking community, is very strong. Although our revenue growth has been impressive, we believe our stock price has been affected as a result of our net loss; therefore, we are refocusing and prioritizing our core business.
Given our proficiency at spotting trends in niche markets and using that information to stay ahead of the competition, we were and will continue to be on the forefront of the industrial hemp/CBD market. Currently, we are excited about initial market tests for a hemp-infused wrinkle cream that will launch soon in China. As product margins seem to be healthier in this market, the Company’s main focus for its industrial hemp business in FY 2020 will be on its China operations where we have a robust product development pipeline. While cannabis use in China is illegal, cannabis-based oils including industrial hemp extract may be added to cosmetics, thus opening a potential market of nearly 1.4 billion people for the Company. As we analyze the legality/trends in other Asian countries, we have an advantage with “feet on the ground” in that part of the world.
Continue Reading
|
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
